Yixintang Pharmaceutical Group Co., Ltd. Stock

Equities

002727

CNE100001WJ8

Drug Retailers

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
19.85 CNY -0.90% Intraday chart for Yixintang Pharmaceutical Group Co., Ltd. -2.12% -14.29%
Sales 2023 * 18.33B 2.53B Sales 2024 * 20.16B 2.78B Capitalization 11.83B 1.63B
Net income 2023 * 1.04B 144M Net income 2024 * 944M 130M EV / Sales 2023 -
Net cash position 2023 * 2.17B 299M Net cash position 2024 * 2.89B 399M EV / Sales 2024 * 0.44 x
P/E ratio 2023 *
11.3 x
P/E ratio 2024 *
10.6 x
Employees 33,176
Yield 2023 *
1.18%
Yield 2024 *
1.86%
Free-Float 52.27%
More Fundamentals * Assessed data
Dynamic Chart
Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Yixintang Pharmaceutical Group Co., Ltd. completed the acquisition of Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd. CI
Yunzhong Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Yixintang Pharmaceutical Group Co., Ltd. and another investor CI
Yixintang Pharmaceutical Group Co., Ltd. agreed to acquire Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd. for CNY 8.40 million. CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Yixintang Pharmaceutical to Buy 43 Stores From Local Peer For 87 Million Yuan MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yixin Convenience Store Chain Co., Ltd. announced that it expects to receive CNY 38 million in funding from Yixintang Pharmaceutical Group Co., Ltd. CI
Yixintang Pharmaceutical Group Co., Ltd. announced a financing transaction CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day-0.84%
1 week-1.23%
Current month+4.98%
1 month+3.84%
3 months+1.52%
6 months-4.57%
Current year-13.51%
More quotes
1 week
19.92
Extreme 19.92
21.00
1 month
18.50
Extreme 18.5
21.00
Current year
16.81
Extreme 16.81
24.57
1 year
16.81
Extreme 16.81
30.33
3 years
16.81
Extreme 16.81
44.80
5 years
16.81
Extreme 16.81
50.10
10 years
7.32
Extreme 7.32
50.10
More quotes
Managers TitleAgeSince
Founder 58 00-11-07
Director of Finance/CFO 42 04-12-31
Director/Board Member 47 00-02-29
Members of the board TitleAgeSince
Founder 58 00-11-07
Director/Board Member 59 09-05-31
Public Communications Contact 37 09-12-31
More insiders
Date Price Change Volume
24-04-23 19.85 -0.90% 6 151 948
24-04-23 20.03 -0.84% 4,231,451
24-04-22 20.2 -1.56% 4,876,308
24-04-19 20.52 -0.58% 4,723,093
24-04-18 20.64 +0.68% 7,486,634

End-of-day quote Shenzhen S.E., April 22, 2024

More quotes
Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company distributes its products through regular chain drugstores. The Company mainly operates its business in domestic market, with southwest area of China as its main market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
20.03 CNY
Average target price
27.74 CNY
Spread / Average Target
+38.49%
Consensus
  1. Stock Market
  2. Equities
  3. 002727 Stock